Table 3.

Baseline clinical data and serum parameters in all 232 patients on dialysisa

Age at study entry65.7 ± 13.7
Gender female/male119/113
Time on dialysis (yr)5.1 ± 4.9
BMI (kg/m2)25.2 ± 4.6
Serum albumin (g/dl)3.7 ± 0.3
Serum creatinine (mg/dl)8.87 ± 2.23
CRP (mg/dl)1.24 ± 1.29
TNT (μ g/l)0.13 ± 0.46
Total cholesterol (mg/dl)204.3 ± 56.4
LDL (mg/dl)111.5 ± 36.6
HDL (mg/dl)42.5 ± 12.0
Triglycerides (mmol/L)188.3 ± 117.5
Fibrinogen (mg/dl)450.1 ± 116.3
D-dimers (mg/L)1.05 ± 1.45
BNP (pg/ml)14.56 ± 35.80
sCD154 (ng/ml)9.1 ± 3.6
  • a Hypertension was defined according to the Guidelines of the European Society of Hypertension or the need for any antihypertensive treatment. Coronary heart disease was diagnosed when the patients had a history of myocardial infarction, coronary heart disease confirmed by coronary angiograms, or typical stable angina confirmed by stress echocardiography or radionuclide studies. The underlying renal diseases were diabetic nephropathy in 68 cases, hypertensive nephrosclerosis in 37 cases, chronic glomerulonephritis in 42 cases, autosomal polycystic kidney disease in 18 cases, interstitial nephritis (mainly analgesic nephropathy) in 33 cases, congenital urinary tract malformations in five cases, and hemolytic uremic syndrome in two cases; the remaining 25 patients had other rare diseases or the renal disease was unknown.